| Study identification | First author, year of publication |
| Clinical features and settings | Previous testing and clinical setting including country where the study was conducted. Presentation at recruitment, prior treatment that would affect the ACD (i.e. peripheral iridotomy, iridoplasty, etc.) |
| Participants | Sample size, age, sex, ethnicity and country |
| Study design | Whether the sample was selected as a single group (consecutive series) or as separate groups with and without the target condition (case‐control). Whether participants were consecutively enrolled in the study and were identified retrospectively or prospectively. Training involved for index tests, both eyes included in the study |
| Target condition | An occludable angle as a referable condition, which includes PACS, PAC and PACG |
| Reference standard | The reference standard test used: gonioscopy for diagnosing an occludable angle; this is acceptable if this is the only target condition in large‐scale screening or primary‐care settings. Gonioscopy combined with tonometry, visual fields investigation and optic disc assessment for distinguishing the relative subgroup of participants with an occludable angle as PACS/PAC/PACG |
| Index tests | Oblique flashlight test: grade recorded LACD using the van Herick technique: van Herick grade, or percentage, or both SPAC: numerical or categorical grade, or both Scheimpflug photography: ACA, ACV and ACD AS‐OCT: model of OCT device, manufacturer and any technical characteristics (e.g. software analyses). TISA, ARA, AOD 500 microns and 750 microns for each parameter |
| Follow up | Numbers of participants lost to follow‐up or who had uninterpretable test results |
| Notes | Source of funding, anything else of relevance |